Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
Listed Suppliers
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Fillers, Diluents & Binders
Lubricants & Glidants
Direct Compression
Co-Processed Excipients
Granulation
Thickeners and Stabilizers
Parenteral
Topical
Controlled & Modified Release
Emulsifying Agents
ABOUT THIS PAGE
A Zeranol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zeranol, including repackagers and relabelers. The FDA regulates Zeranol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zeranol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Zeranol supplier is an individual or a company that provides Zeranol active pharmaceutical ingredient (API) or Zeranol finished formulations upon request. The Zeranol suppliers may include Zeranol API manufacturers, exporters, distributors and traders.
click here to find a list of Zeranol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Zeranol DMF (Drug Master File) is a document detailing the whole manufacturing process of Zeranol active pharmaceutical ingredient (API) in detail. Different forms of Zeranol DMFs exist exist since differing nations have different regulations, such as Zeranol USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Zeranol DMF submitted to regulatory agencies in the US is known as a USDMF. Zeranol USDMF includes data on Zeranol's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Zeranol USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Zeranol suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Zeranol as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Zeranol API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Zeranol as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Zeranol and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Zeranol NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Zeranol suppliers with NDC on PharmaCompass.
Zeranol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Zeranol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Zeranol GMP manufacturer or Zeranol GMP API supplier for your needs.
A Zeranol CoA (Certificate of Analysis) is a formal document that attests to Zeranol's compliance with Zeranol specifications and serves as a tool for batch-level quality control.
Zeranol CoA mostly includes findings from lab analyses of a specific batch. For each Zeranol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Zeranol may be tested according to a variety of international standards, such as European Pharmacopoeia (Zeranol EP), Zeranol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Zeranol USP).
LOOKING FOR A SUPPLIER?
